Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Abingdon Health Plc LSE:ABDX London Ordinary Share GB00BLF79J41 ORD 0.025P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.75 7.5% 10.75 10.50 11.00 10.75 10.00 10.00 279,813 16:16:38
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services - - - - 13

Abingdon Health PLC Publication of Annual Report and Notice of AGM

03/12/2021 11:06am

UK Regulatory (RNS & others)


Abingdon Health (LSE:ABDX)
Historical Stock Chart


From Nov 2021 to May 2022

Click Here for more Abingdon Health Charts.

TIDMABDX

RNS Number : 5337U

Abingdon Health PLC

03 December 2021

Abingdon Health plc

("Abingdon Health", the "Group" or the "Company")

Publication of Annual Report and Accounts and Notice of Annual General Meeting

York, U.K. 3 December 2021: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality and effective rapid tests, is pleased to announce is pleased to announce that its Annual General Meeting ('AGM') will be held on Friday 24 December at 9.30 a.m. at the offices of Abingdon Health, York Biotech Campus, Sand Hutton, York, YO41 1LZ, United Kingdom.

Given the continued uncertainty relating to COVID-19, shareholders are encouraged to vote by proxy in advance of the AGM or appointing the chair of the meeting as their proxy.

The Company's Annual Report and Accounts for the year ended 30 June 2021 together with the notice convening the AGM and related form of proxy has been sent to shareholders and is available on the Company's website www.abingdonhealth.com.

Enquiries:

 
 Abingdon Health plc                                   www.abingdonhealth.com/investors/ 
 Chris Yates, Chief Executive Officer                                    Via Walbrook PR 
 Melanie Ross , Chief Financial Officer 
 Christopher Hand, Non-Executive Chairman 
 
 Singer Capital Markets (Sole Broker and                        Tel: +44 (0)20 7496 3000 
  Nominated Adviser) 
 Shaun Dobson, Peter Steel, Alex Bond (Corporate 
  Finance) 
 Tom Salvesen (Corporate Broking) 
 
 Walbrook PR Limited                 Tel: +44 (0)20 7933 8780 or abingdon@walbrookpr.com 
 Paul McManus / Phillip                       Mob: +44 (0)7980 541 893 / +44 (0)7867 984 
  Marriage                                                                           082 
 Alice Woodings                                                 Mob: +44 (0)7407 804 654 
 
 

About Abingdon Health

Abingdon Health is a world leading developer and manufacturer of high-quality rapid tests across all industry sectors, including healthcare and COVID-19. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and has also developed and marketed its own labelled tests.

The Company offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes. This ability has a significant role to play in improving life across the world. To support this aim Abingdon Health has also developed AppDx(R) , a customisable image capturing technology that transforms a smartphone into a self-sufficient, standalone lateral-flow reader.

Founded in 2008, Abingdon Health is headquartered in York, England.

For more information visit: www.abingdonhealth.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACSBBBDDSGGDGBX

(END) Dow Jones Newswires

December 03, 2021 06:06 ET (11:06 GMT)

1 Year Abingdon Health Chart

1 Year Abingdon Health Chart

1 Month Abingdon Health Chart

1 Month Abingdon Health Chart
ADVFN Advertorial
Your Recent History
LSE
ABDX
Abingdon H..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220529 12:31:30